Alterity Therapeutics Limited (NASDAQ:ATHE – Get Free Report) saw a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 56,800 shares, an … [+2412 chars]...
Read moreA few weeks ago, I got to give a talk at the University of Miami. The focus: six myths about contracts, as many of us teach contract law (or at least as I teach it). The talk was a blast -- the fac… [+3325 chars]...
Read moreMilans season may have veered off course in the Serie A title race, but in the Coppa Italia, the Rossoneri have rediscovered a sparkone thats flared most brightly against their fiercest rivals, Inter… [+3088 chars]...
Read moreMELBOURNE, Australia and SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (Alterity or the Company), a biotechnology company dedicated to developing di… [+10201 chars]...
Read moreI fear I am learning this from my boss, based on his neurodivergence and subtle misogynistic behaviour I see but I can't seem to point out to him, but he has to know that companies who identify, inte… [+2469 chars]...
Read moreFast Track Designation highlights potential of ATH434 to address high unmet need for individuals with MSA MELBOURNE, Australia and SAN FRANCISCO, May 05, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeut… [+10292 chars]...
Read more